1 - 17 out of 17Page size: 20
  1. 2024

  2. Mechanistic Insights of hsa-mir-301a Regulation by Tobacco Smoke in Lung Squamous Cell Carcinoma: Evidence From Bioinformatics Analysis

    Pustylnyak, V. O., Perevalova, A. M. & Gulyaeva, L. F., 5 Dec 2024, In: Bioinformatics and Biology Insights. 18, p. 1-8 8 p.

    Research output: Contribution to journal › Article › peer-review

  3. Smoking-Mediated miR-301a/IRF1 Axis Controlling Immunotherapy Response in Lung Squamous Cell Carcinoma Revealed by Bioinformatic Analysis

    Perevalova, A. M., Kononchuk, V. V., Kalinina, T. S., Kozlov, V. V., Gulyaeva, L. F. & Pustylnyak, V. O., Jun 2024, In: Cancers. 16, 12, 2208.

    Research output: Contribution to journal › Article › peer-review

  4. Expression of AhR-regulated miRNAs in non-small cell lung cancer in smokers and never smokers

    Kalinina, T. S., Kononchuk, V. V., Valembakhov, I. S., Pustylnyak, V. O., Kozlov, V. V. & Gulyaeva, L. F., Feb 2024, In: Biomeditsinskaia khimiia. 70, 1, p. 52-60 9 p.

    Research output: Contribution to journal › Article › peer-review

  5. Roles of Interferon Regulatory Factor 1 in Tumor Progression and Regression: Two Sides of a Coin

    Perevalova, A. M., Gulyaeva, L. F. & Pustylnyak, V. O., Feb 2024, In: International Journal of Molecular Sciences. 25, 4, 18 p., 2153.

    Research output: Contribution to journal › Article › peer-review

  6. 2023

  7. Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation

    Mazin, M. E., Perevalova, A. M., Yarushkin, A. A., Pustylnyak, Y. A., Rogachev, A. D., Prokopyeva, E. A., Gulyaeva, L. F. & Pustylnyak, V. O., Aug 2023, In: Biochemistry (Moscow). 88, 8, p. 1061-1069 9 p.

    Research output: Contribution to journal › Article › peer-review

  8. Tumor suppressor PTEN regulation by tobacco smoke in lung squamous-cell carcinoma based on bioinformatics analysis

    Pustylnyak, V. O., Alekseenok, E. Y., Perevalova, A. M., Kozlov, V. V. & Gulyaeva, L. F., Aug 2023, In: Heliyon. 9, 8, 10 p., e19044.

    Research output: Contribution to journal › Article › peer-review

  9. 2022

  10. Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium

    Perevalova, A. M., Kobelev, V. S., Sisakyan, V. G., Gulyaeva, L. F. & Pustylnyak, V. O., Nov 2022, In: Biochemistry (Moscow). 87, 11, p. 1310-1326 17 p.

    Research output: Contribution to journal › Review article › peer-review

  11. Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation

    Mazin, M. E., Yarushkin, A. A., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., May 2022, In: Molecular Biology Reports. 49, 5, p. 4089-4093 5 p.

    Research output: Contribution to journal › Article › peer-review

  12. 2021

  13. miRNA expression and interaction with the 3′UTR of FMR1 in FRAXopathy pathogenesis

    Dolskiy, A. A., Yarushkin, A. A., Grishchenko, I. V., Lemskaya, N. A., Pindyurin, A. V., Boldyreva, L. V., Pustylnyak, V. O. & Yudkin, D. V., Mar 2021, In: Non-coding RNA Research. 6, 1, p. 1-7 7 p.

    Research output: Contribution to journal › Article › peer-review

  14. 2020

  15. Noncanonical constitutive androstane receptor signaling in gene regulation

    Pustylnyak, Y. A., Gulyaeva, L. F. & Pustylnyak, V. O., 14 Sept 2020, In: International Journal of Molecular Sciences. 21, 18, p. 1-10 10 p., 6735.

    Research output: Contribution to journal › Review article › peer-review

  16. Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation

    Yarushkin, A. A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 15 Jul 2020, In: European Journal of Pharmacology. 879, 5 p., 173135.

    Research output: Contribution to journal › Article › peer-review

  17. 2019

  18. Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN

    Yarushkin, A. A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 15 Sept 2019, In: Archives of Biochemistry and Biophysics. 672, p. 108065 7 p., 108065.

    Research output: Contribution to journal › Article › peer-review

  19. 2018

  20. CAR-mediated repression of Cdkn1a(p21) is accompanied by the Akt activation

    Yarushkin, A. A., Mazin, M. E., Yunusova, A. Y., Korchagina, K. V., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 2 Oct 2018, In: Biochemical and Biophysical Research Communications. 504, 2, p. 361-366 6 p.

    Research output: Contribution to journal › Article › peer-review

  21. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients

    Geletina, N. S., Kobelev, V. S., Babayants, E. V., Feng, L., Pustylnyak, V. O. & Gulyaeva, L. F., 20 May 2018, In: Gene. 655, p. 20-24 5 p.

    Research output: Contribution to journal › Article › peer-review

  22. Increased expression of miR-155 and miR-222 is associated with lymph node positive status

    Chernyy, V., Pustylnyak, V., Kozlov, V. & Gulyaeva, L., 1 Jan 2018, In: Journal of Cancer. 9, 1, p. 135-140 6 p.

    Research output: Contribution to journal › Article › peer-review

  23. 2017

  24. Peroxisome proliferator-activated receptor γ activation inhibits liver growth through miR-122-mediated downregulation of cMyc

    Yarushkin, A. A., Kazantseva, Y. A., Kobelev, V. S., Pustylnyak, Y. A. & Pustylnyak, V. O., 15 Feb 2017, In: European Journal of Pharmacology. 797, p. 39-44 6 p.

    Research output: Contribution to journal › Article › peer-review

  25. Inhibitors of Histone Deacetylases Are Weak Activators of the FMR1 Gene in Fragile X Syndrome Cell Lines

    Dolskiy, A. A., Pustylnyak, V. O., Yarushkin, A. A., Lemskaya, N. A. & Yudkin, D. V., 1 Jan 2017, In: BioMed Research International. 2017, p. 3582601 5 p., 3582601.

    Research output: Contribution to journal › Article › peer-review

ID: 3444310